Healthtech Seed Investors & VC Firms
2488 firms in this list, with a median first check of $440.5K. 582 of them lead rounds. Generated from verified public data and updated continuously.
Elron Ventures
Tel AvivSeed–Series B$1M – $17M
2 people
GBS Venture Partners Ltd.
MelbourneSeed–Growth$165K – $7.9M
2 people
Hiventures
BudapestSeed–Late Stage$43.2K – $43.2M
2 people
MAPE Advisory Group
BangaloreSeed$54K – $95M
2 people
Nissay Capital
TokyoPre-Seed–Late Stage$610K – $71M
1 person
Gaorong Capital
BeijingSeed–Series B
4 people
SmartHealth Catalyzer
ChicagoPre-Seed–Seed
1 person
re.Mind Capital
LondonPre-Seed–Series A
3 people
1 4 All Group
DubaiSeed–Series A$50K – $14M
1 person
Annox Capital
BirminghamSeed–Late Stage$100K – $30M
1 person
Cutlass Capital, L.L.C.
BostonSeed–Late Stage$3M – $7M
1 person
FFG Venture Business Partners
FukuokaPre-Seed–Late Stage$1M – $50M
1 person
Gentree Fund
SingaporeSeed–Series C$1M – $60M
1 person
Japan Asia Investment
TokyoPre-Seed–Late Stage$1M – $10M
1 person
Primary Care Innovation Fund
PhiladelphiaSeed–Series A$100K – $1M
1 person
Stella Maris Partners
MonterreySeed–Series A$250K – $1M
1 person
Yaya Capital
MiamiSeed–Series A$300K – $5M
1 person
Arcus Ventures
New YorkSeed–Series A
4 people
BioTrack Capital
Grand CaymanSeed–Late Stage
4 people
Mitsubishi UFJ Capital
TokyoPre-Seed–Late Stage$952K – $269M
CIBC
ChicagoPre-Seed–Late Stage$1.5M – $29.2M
TrueSight Ventures
EsherPre-Seed–Series A
3 people
Almak Capital
AlmatyPre-Seed–Seed$400K
Ameba Capital
ShanghaiSeed–Late Stage
3 people
Related lists
Seed Investors & VC Firms (10665)Seed Investors & VC Firms in United States (3953)Healthtech Investors & VC Firms (3208)AI & Machine Learning Seed Investors & VC Firms (2915)SaaS Seed Investors & VC Firms (2915)Seed Investors & VC Firms in Global (2665)Fintech Seed Investors & VC Firms (2600)Enterprise Software Seed Investors & VC Firms (2451)Healthtech Series A Investors & VC Firms (2210)Deep Tech Seed Investors & VC Firms (2002)
Data sourced from public filings and firms' own websites — see our methodology.








